Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Report Date
Dr. Robert S. LangerN/A950,0221.6%2008-08-08
Alan L. CraneDirector613,8201.03%2010-04-14
Genesh Venkataraman Kaundinya, PhDSenior V.P., Research388,7850.65%2015-05-20
Dr. Ram Sasisekharan,PhDDirector340,2740.57%2010-07-23
Steven B. BruggerCOO264,9180.45%2010-10-28
Craig A. WheelerPresident218,3120.37%2015-06-18
Dr. John L. Zabriskie,PhDN/A149,5980.25%2004-06-25
Richard P. SheaSVP, CFO144,0480.24%2015-05-20
Bruce A. LeicherSVP & General Counsel117,8170.2%2015-06-18
Dr. James M. Roach,M.D.Senior VP, Development and Chi105,9020.18%2015-06-18

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Stoner ElizabethDirector2015-07-15Sell4,57013,240$22.35102.1-2.7313,240 (Direct)
Bishop John ESenior VP, Pharmaceutical Scie2015-06-19Sell21,27499,380$25.5542.5-14.7599,380 (Direct)
Bishop John ESenior VP, Pharmaceutical Scie2015-06-18Sell36,31399,380$23.58856.3-7.899,380 (Direct)
Roach James M.Senior VP, Development and Chi2015-06-18Sell25,000105,902$23.7592.5-8.27105,902 (Direct)
Leicher BruceSVP & General Counsel2015-06-18Sell20,000117,817$23460-5.48117,817 (Direct)
WHEELER CRAIG APresident2015-06-18Sell155,000549,344$24.23751-10.17218,312 (Direct)
181,032 (Craig Wheeler Revocable Trust)
150,000 (Craig A. Wheeler 2014 Irrevocable Trust)
Franken MichaelPresident, Biosimilars Busines2015-06-11Sell51239,001$22.3711.5-2.8239,001 (Direct)
WHEELER CRAIG APresident2015-06-04Sell103,333579,344$222273.3-1.18218,312 (Direct)
211,032 (Craig Wheeler Revocable Trust)
150,000 (Craig A. Wheeler 2014 Irrevocable Trust)
Leicher BruceSVP & General Counsel2015-06-01Sell40,000117,817$218403.52117,817 (Direct)
Roach James M.Senior VP, Development and Chi2015-06-01Sell25,000105,902$21.7542.50.18105,902 (Direct)
Bishop John ESenior VP, Pharmaceutical Scie2015-05-26Sell254110,380$19.859.8110,380 (Direct)
Shea Richard PSVP, CFO
(Click for the stocks that their CFOs have bought)
2015-05-20Sell227144,048$19.684.510.47144,048 (Direct)
Leicher BruceSVP & General Counsel2015-05-20Sell227117,817$19.684.510.47117,817 (Direct)
Roach James M.Senior VP, Development and Chi2015-05-20Sell360105,902$19.687.110.47105,902 (Direct)
WHEELER CRAIG APresident2015-05-20Sell1,766599,344$19.6834.810.47224,594 (Direct)
224,750 (Craig Wheeler Revocable Trust)
150,000 (Craig A. Wheeler 2014 Irrevocable Trust)
Bishop John ESenior VP, Pharmaceutical Scie2015-05-20Sell227110,634$19.684.510.47110,634 (Direct)
Kaundinya Ganesh VenkataramanSenior V.P., Research2015-05-20Sell227388,785$19.684.510.47388,785 (Direct)
Leicher BruceSVP & General Counsel2015-05-19Sell426118,044$19.638.410.75118,044 (Direct)
Bishop John ESenior VP, Pharmaceutical Scie2015-05-19Sell624110,861$19.6312.210.75110,861 (Direct)
Kaundinya Ganesh VenkataramanSenior V.P., Research2015-05-19Sell406389,012$19.63810.75389,012 (Direct)

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership